Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has 9 years of Interest Coverage Ratio data on file, last reported at 0.45 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 89.64% year-over-year to 0.45 in Q1 2026; TTM through Mar 2026 was 2.82, a 29.45% increase from a year earlier, with the FY2025 full-year figure at 1.99, down 82.87% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.45, down from 0.36 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for PHAT reached as high as 0.36 in Q4 2025 and fell as low as 13.54 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 4.14 across 5 years, with a median of 3.26 in 2023.
• Across the five-year window, Interest Coverage Ratio tumbled 684.34% in 2022 and soared 89.64% in 2026, its largest moves.
• Year by year, Interest Coverage Ratio stood at 12.27 in 2022, then surged by 83.13% to 2.07 in 2023, then slumped by 54.33% to 3.2 in 2024, then soared by 88.7% to 0.36 in 2025, then decreased by 25.23% to 0.45 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.45 in Q1 2026, 0.36 in Q4 2025, and 0.37 in Q3 2025.